• 2568 引文
  • 28 h-指數
20042019
如果您對這些純文本內容做了任何改變,很快就會看到。

研究成果 2004 2019

2019
3 引文 (Scopus)

A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life

Chou, W. C., Chen, J. S., Hung, C. Y., Lu, C. H., Shao, Y. Y., Chiou, T. J., Sung, Y. C., Rau, K. M., Yen, C-J., Yeh, S. P., Liu, T. C., Wu, M. F., Lee, M. Y., Yu, M. S., Hwang, W. L., Lai, P. Y., Chang, C. S. & Hsieh, R. K., 2019 八月 1, 於 : Supportive Care in Cancer. 27, 8, p. 2857-2867 11 p.

研究成果: Article

Taiwan
Analgesics
Quality of Life
Neoplasms
Pain

CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity

Chen, R. Y., Yen, C. J., Liu, Y. W., Guo, C. G., Weng, C. Y., Lai, C. H., Wang, Y. M., Lin, Y. J. & Hung, L. Y., 2019 一月 1, (Accepted/In press) 於 : Cell Death and Differentiation.

研究成果: Article

Neoplasm Metastasis
Hepatocellular Carcinoma
Proteins
Interleukin-8
Interleukin-6

Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Lu, L. C., Hsu, C., Shao, Y. Y., Chao, Y., Yen, C-J., Shih, I. L., Hung, Y. P., Chang, C. J., Shen, Y. C., Guo, J. C., Liu, T. H., Hsu, C. H. & Cheng, A. L., 2019 一月 1, (Accepted/In press) 於 : Liver Cancer.

研究成果: Article

開啟存取
Hepatocellular Carcinoma
Liver
Neoplasms
Lung
Monoclonal Antibodies

Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial

Yoshikawa, T., Muro, K., Shitara, K., Oh, D. Y., Kang, Y. K., Chung, H. C., Kudo, T., Chin, K., Kadowaki, S., Hamamoto, Y., Hironaka, S., Yoshida, K., Yen, C-J., Omuro, Y., Bai, L. Y., Maeda, K., Ozeki, A., Yoshikawa, R. & Kitagawa, Y., 2019 八月 2, 於 : JAMA network open. 2, 8, p. e198243

研究成果: Article

開啟存取
oxaliplatin
Far East
Paclitaxel
Stomach Neoplasms
Randomized Controlled Trials

Generation of a heterozygous p53 R249S mutant human embryonic stem cell line by TALEN-mediated genome editing

Huo, Z., Tu, J., Xu, A., Li, Y., Wang, D., Liu, M., Zhou, R., Zhu, D., Lin, Y., Gingold, J. A., Yen, C-J., Xiao, H. & Zhao, R., 2019 一月 1, 於 : Stem Cell Research. 34, 101360.

研究成果: Article

開啟存取
Cell Line
Mutation
Germ Layers
Teratoma
Liver Neoplasms

Hepatitis B virus X protein (HBx) enhances centrosomal P4.1-associated protein (CPAP) expression to promote hepatocarcinogenesis

Yen, C-J., Yang, S. T., Chen, R. Y., Huang, W-Y., Chayama, K., Lee, M. H., Yang, S. J., Lai, H. S., Yen, H. Y., Hsiao, Y. W., Wang, J-M., Lin, Y-J. & Hung, L-Y., 2019 六月 6, 於 : Journal of biomedical science. 26, 1, 44.

研究成果: Article

開啟存取
Proteins
Hepatocellular Carcinoma
Viruses
Hepatitis B virus
Cyclic AMP Response Element-Binding Protein
1 引文 (Scopus)

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design

Moehler, M., Ryu, M. H., Dvorkin, M., Lee, K. W., Coşkun, H., Wong, R., Chung, H. C., Poltoratsky, A., Tsuji, A., Yen, C. J., Muntean, A. S., Le Sourd, S., Vaccaro, G. M., Overton, L., Boku, N., Wainberg, Z. A., Patel, M., Sharma, M., Xiong, H., Conti, I. 及其他2, Taieb, J. & Bang, Y. J., 2019 二月, 於 : Future Oncology. 15, 6, p. 567-577 11 p.

研究成果: Article

開啟存取
Stomach Neoplasms
Esophagogastric Junction
Stomach
oxaliplatin
Maintenance

Multimodal exercise ameliorates exercise responses and body composition in head and neck cancer patients receiving chemotherapy

Yen, C. J., Hung, C. H., Kao, C. L., Tsai, W. M., Chan, S. H., Cheng, H. C., Jheng, W. T., Lu, Y. J. & Tsai, K. L., 2019 十二月 1, 於 : Supportive Care in Cancer. 27, 12, p. 4687-4695 9 p.

研究成果: Article

Head and Neck Neoplasms
Body Composition
Exercise
Drug Therapy
Heart Rate

Oral hygiene and the overall survival of head and neck cancer patients

Chang, C-C., Lee, W-T., Hsiao, J-R., Ou, C-Y., Huang, C-C., Tsai, S-T., Chen, K-C., Huang, J-S., Wang, D-Y., Lai, Y-H., Wu, Y-H., Hsueh, W-T., Wu, S-Y., Yen, C-J., Chang, J-Y., Lin, C. L., Weng, Y. L., Yang, H. C., Chen, Y. S. & Chang, J. S., 2019 四月 1, 於 : Cancer medicine. 8, 4, p. 1854-1864 11 p.

研究成果: Article

開啟存取
Oral Hygiene
Head and Neck Neoplasms
Survival
Confidence Intervals
Tooth

Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study

Cho, S. F., Rau, K. M., Shao, Y. Y., Yen, C-J., Wu, M. F., Chen, J. S., Chang, C. S., Yeh, S. P., Chiou, T. J., Hsieh, R. K., Lee, M. Y., Sung, Y. C., Lee, K. D., Lai, P. Y., Yu, M. S., Hwang, W. L. & Liu, T. C., 2019 五月 1, 於 : Supportive Care in Cancer. 27, 5, p. 1663-1672 10 p.

研究成果: Article

Pain Management
Head and Neck Neoplasms
Pain
Walking
Analgesics
56 引文 (Scopus)
Fetal Proteins
Hepatocellular Carcinoma
Placebos
sorafenib
ramucirumab
1 引文 (Scopus)
Neoadjuvant Therapy
Squamous Cell Carcinoma
Clinical Trials
Staining and Labeling
Neoplasms
Head and Neck Neoplasms
Alcohols
Surveys and Questionnaires
Alleles
Validation Studies
2018
5 引文 (Scopus)

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH study

Chau, I., Park, J. O., Ryoo, B. Y., Yen, C-J., Poon, R., Pastorelli, D., Blanc, J. F., Kudo, M., Pfiffer, T., Hatano, E., Chung, H. C., Kopeckova, K., Phelip, J. M., Brandi, G., Ohkawa, S., Li, C. P., Okusaka, T., Hsu, Y., Abada, P. B. & Zhu, A. X., 2018 七月 3, 於 : British Journal of Cancer. 119, 1, p. 19-26 8 p.

研究成果: Article

alpha-Fetoproteins
Hepatocellular Carcinoma
Placebos
Survival
Therapeutics
4 引文 (Scopus)

A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma

Yen, C-J., Kim, T. Y., Feng, Y. H., Chao, Y., Lin, D. Y., Ryoo, B. Y., Huang, D. C. L., Schnell, D., Hocke, J., Loembé, A. B. & Cheng, A. L., 2018 五月 1, 於 : Liver Cancer. 7, 2, p. 165-178 14 p.

研究成果: Article

Hepatocellular Carcinoma
Pharmacokinetics
Safety
Maximum Tolerated Dose
Aspartate Aminotransferases
2 引文 (Scopus)

Corrigendum to ‘Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study’ [Eur J Canc 81 (2017) 17–25] (S0959804917309334) (10.1016/j.ejca.2017.05.001))

Chau, I., Peck-Radosavljevic, M., Borg, C., Malfertheiner, P., Seitz, J. F., Park, J. O., Ryoo, B. Y., Yen, C-J., Kudo, M., Poon, R., Pastorelli, D., Blanc, J. F., Chung, H. C., Baron, A. D., Okusaka, T., Bowman, L., Cui, Z. L., Girvan, A. C., Abada, P. B., Yang, L. 及其他1, Zhu, A. X., 2018 九月 1, 於 : European Journal of Cancer. 100, p. 135-136 2 p.

研究成果: Comment/debate

Hepatocellular Carcinoma
Stomach
Emotions
Pain
Therapeutics
4 引文 (Scopus)

Exposure–response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

Kim, T. Y., Yen, C-J., Al-Batran, S. E., Ferry, D., Gao, L., Hsu, Y., Cheng, R., Orlando, M. & Ohtsu, A., 2018 三月 1, 於 : Gastric Cancer. 21, 2, p. 276-284 9 p.

研究成果: Article

Stomach Neoplasms
Randomized Controlled Trials
Therapeutics
Esophagogastric Junction
Paclitaxel

Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection

Yen, C., Ai, Y., Tsai, H., Chan, S., Yen, C., Cheng, K., Lee, Y., Kao, C., Wang, Y., Chen, Y., Lin, C., Liu, T., Tsai, H., Wang, J., Su, I. & Huang, W., 2018 九月 1, 於 : Hepatology. 68, 3, p. 815-826

研究成果: Article

5 引文 (Scopus)

Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection

Yen, C. J., Ai, Y. L., Tsai, H. W., Chan, S. H., Yen, C. S., Cheng, K. H., Lee, Y. P., Kao, C. W., Wang, Y. C., Chen, Y. L., Lin, C. H., Liu, T., Tsai, H. P., Wang, J. R., Su, I. J. & Huang, W., 2018 九月, 於 : Hepatology. 68, 3, p. 815-826 12 p.

研究成果: Article

Hepatitis B virus
Hepatocellular Carcinoma
Biomarkers
Recurrence
Surface Antigens
15 引文 (Scopus)

Hepatocellular carcinoma–related cyclin D1 is selectively regulated by autophagy degradation system

Wu, S. Y., Lan, S. H., Wu, S-R., Chiu, Y. C., Lin, X-Z., Su, I. J., Tsai, T. F., Yen, C-J., Lu, T-H., Liang, F. W., Li, C-Y., Su, H-J., Su, C. L. & Liu, H-S., 2018 七月 1, 於 : Hepatology. 68, 1, p. 141-154 14 p.

研究成果: Article

Cyclin D1
Autophagy
Hepatocellular Carcinoma
Neoplasms
Carcinogenesis
1 引文 (Scopus)

NEK2 promotes hepatoma metastasis and serves as biomarker for high recurrence risk after hepatic resection

Chang, Y. Y., Yen, C-J., Chan, S-H., Chou, Y. W., Lee, Y. P., Bao, C. Y., Huang, C. J. & Huang, W-Y., 2018 九月 1, 於 : Annals of Hepatology. 17, 5, p. 843-856 14 p.

研究成果: Article

Hepatocellular Carcinoma
Biomarkers
Neoplasm Metastasis
Recurrence
Liver

NEK2 Promotes Hepatoma Metastasis and Serves as Biomarker for High Recurrence Risk after Hepatic Resection

Chang, Y., Yen, C., Chan, S., Chou, Y., Lee, Y., Bao, C., Huang, C. & Huang, W., 2018 八月 24, 於 : Annals of Hepatology. 17, 5, p. 843-856

研究成果: Article

105 引文 (Scopus)
Esophageal Neoplasms
Paclitaxel
Stomach
Cell Death
Survival
23 引文 (Scopus)

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Abou-Alfa, G. K., Qin, S., Ryoo, B. Y., Lu, S. N., Yen, C-J., Feng, Y. H., Lim, H. Y., Izzo, F., Colombo, M., Sarker, D., Bolondi, L., Vaccaro, G., Harris, W. P., Chen, Z., Hubner, R. A., Meyer, T., Sun, W., Harding, J. J., Hollywood, E. M., Ma, J. 及其他7, Wan, P. J., Ly, M., Bomalaski, J., Johnston, A., Lin, C. C., Chao, Y. & Chen, L. T., 2018 六月 1, 於 : Annals of Oncology. 29, 6, p. 1402-1408 7 p.

研究成果: Article

Arginine
Hepatocellular Carcinoma
Patient Care
Placebos
Survival
3 引文 (Scopus)

Phase II studies with refametinib or refametinib plus sorafenib in patients with RAS-mutated hepatocellular Carcinoma

Lim, H. Y., Merle, P., Weiss, K. H., Yau, T., Ross, P., Mazzaferro, V., Blanc, J. F., Ma, Y. T., Yen, C-J., Kocsis, J., Choo, S. P., Sukeepaisarnjaroen, W., Gerolami, R., Dufour, J. F., Gane, E. J., Ryoo, B. Y., Peck-Radosavljevic, M., Dao, T., Yeo, W., Lamlertthon, W. 及其他7, Thongsawat, S., Teufel, M., Roth, K., Reis, D., Childs, B. H., Krissel, H. & Llovet, J. M., 2018 十月 1, 於 : Clinical Cancer Research. 24, 19, p. 4650-4661 12 p.

研究成果: Article

Hepatocellular Carcinoma
Mutation
DNA
Magnetics
Disease-Free Survival
1 引文 (Scopus)
Progesterone Receptors
Hepatocellular Carcinoma
Biomarkers
Membranes
Atlases
2 引文 (Scopus)

Ramucirumab safety in East Asian patients: A meta-analysis of six global, randomized, double-blind, placebo-controlled, phase III clinical trials

Yen, C-J., Muro, K., Kim, T. W., Kudo, M., Shih, J. Y., Lee, K. W., Chao, Y., Kim, S. W., Yamazaki, K., Sohn, J. H., Cheng, R., Zhang, Y., Binder, P., Mi, G., Orlando, M. & Chung, H. C., 2018 三月 1, 於 : Journal of Global Oncology. 2018, 4

研究成果: Article

開啟存取
Phase III Clinical Trials
Meta-Analysis
Placebos
Safety
ramucirumab

Satisfaction with pain management and impact of pain on quality of life in cancer patients

Lin, J., Hsieh, R. K., Chen, J. S., Lee, K. D., Rau, K. M., Shao, Y. Y., Sung, Y. C., Yeh, S. P., Chang, C. S., Liu, T. C., Wu, M. F., Lee, M. Y., Yu, M. S., Yen, C-J., Lai, P. Y., Hwang, W. L. & Chiou, T. J., 2018 一月 1, (Accepted/In press) 於 : Asia-Pacific Journal of Clinical Oncology.

研究成果: Article

Pain Management
Quality of Life
Pain
Neoplasms
Taiwan
4 引文 (Scopus)
Microbiota
Genetic Polymorphisms
Life Style
Squamous Cell Carcinoma
Oral Hygiene
2017
11 引文 (Scopus)

A phase I/II multicenter study of single-agent foretinib as first-line therapy in patients with advanced hepatocellular carcinoma

Yau, T. C. C., Lencioni, R., Sukeepaisarnjaroen, W., Chao, Y., Yen, C-J., Lausoontornsiri, W., Chen, P. J., Sanpajit, T., Camp, A., Cox, D. S., Gagnon, R. C., Liu, Y., Raffensperger, K. E., Kulkarni, D. A., Kallender, H., Ottesen, L. H., Poon, R. T. P. & Bottaro, D. P., 2017 五月 15, 於 : Clinical Cancer Research. 23, 10, p. 2405-2413 9 p.

研究成果: Article

Multicenter Studies
Hepatocellular Carcinoma
Maximum Tolerated Dose
Interleukin-8
Therapeutics
18 引文 (Scopus)

A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141

Kiyota, N., Hasegawa, Y., Takahashi, S., Yokota, T., Yen, C-J., Iwae, S., Shimizu, Y., Hong, R. L., Goto, M., Kang, J. H., Sum Kenneth Li, W., Ferris, R. L., Gillison, M., Namba, Y., Monga, M., Lynch, M. & Tahara, M., 2017 十月 1, 於 : Oral Oncology. 73, p. 138-146 9 p.

研究成果: Article

Phase III Clinical Trials
Research Personnel
Confidence Intervals
Population
Therapeutics
8 引文 (Scopus)

Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma

Lu, C. Y., Chen, S. Y., Peng, H. L., Kan, P. Y., Chang, W. C. & Yen, C-J., 2017 一月 1, 於 : Oncotarget. 8, 4, p. 6406-6418 13 p.

研究成果: Article

Methylation
Hepatocellular Carcinoma
MicroRNAs
alpha-Fetoproteins
Sensitivity and Specificity
3 引文 (Scopus)

Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus

Liu, W. C., Wu, I-C., Lee, Y. C., Lin, C. P., Cheng, J. H., Lin, Y-J., Yen, C-J., Cheng, P-N., Li, P. F., Cheng, Y. T., Cheng, P. W., Sun, K. T., Yan, S. L., Lin, J. J., Yang, J. C., Chang, K-C., Ho, C. H., Tseng, V. S., Chang, B. C. H., Wu, J. C. 及其他1, Chang, T-T., 2017 十月 1, 於 : Journal of Pathology. 243, 2, p. 176-192 17 p.

研究成果: Article

Hepatitis B virus
Hepatocellular Carcinoma
Nucleotides
Genome
Meta-Analysis
4 引文 (Scopus)

Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan

Shen, W. C., Chen, J. S., Shao, Y. Y., Lee, K. D., Chiou, T. J., Sung, Y. C., Rau, K. M., Yen, C-J., Liao, Y. M., Liu, T. C., Wu, M. F., Lee, M. Y., Yu, M. S., Hwang, W. L., Lai, P. Y., Chang, C. S., Chou, W. C. & Hsieh, R. K., 2017 七月 1, 於 : Journal of Pain and Symptom Management. 54, 1, p. 55-65.e1

研究成果: Article

Taiwan
Analgesics
Patient Care
Outpatients
Pain Management
9 引文 (Scopus)

Inhibition of the EGFR/STAT3/CEBPD Axis reverses cisplatin cross-resistance with paclitaxel in the urothelial carcinoma of the urinary bladder

Wang, W. J., Li, C. F., Chu, Y. Y., Wang, Y. H., Hour, T. C., Yen, C-J., Chang, W. C. & Wang, J-M., 2017 一月 15, 於 : Clinical Cancer Research. 23, 2, p. 503-513 11 p.

研究成果: Article

CCAAT-Enhancer-Binding Protein-delta
Paclitaxel
Cisplatin
Urinary Bladder
NSC 74859
10 引文 (Scopus)
Head and Neck Neoplasms
Taiwan
Alcohols
Hypopharyngeal Neoplasms
Oropharyngeal Neoplasms
4 引文 (Scopus)

Investigating the association between diet and risk of head and neck cancer in Taiwan

Chang, C-C., Lee, W-T., Lee, Y-C., Huang, C-C., Ou, C-Y., Lin, Y. H., Huang, J-S., Wang, D-Y., Chen, K-C., Hsiao, J-R., Lu, Y. C., Tsai, S-T., Lai, Y-H., Wu, Y-H., Hsueh, W-T., Yen, C-J., Wu, S-Y., Chang, J-Y., Fang, S-Y., Wu, J-L. 及其他5, Lin, C. L., Weng, Y. L., Yang, H. C., Chen, Y. S. & Chang, J. S., 2017 一月 1, 於 : Oncotarget. 8, 58, p. 98865-98875 11 p.

研究成果: Article

Head and Neck Neoplasms
Taiwan
Vegetables
Diet
Fruit
24 引文 (Scopus)

mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib

Meyer, T., Palmer, D. H., Cheng, A. L., Hocke, J., Loembé, A. B. & Yen, C-J., 2017 七月 1, 於 : Liver International. 37, 7, p. 1047-1055 9 p.

研究成果: Article

Hepatocellular Carcinoma
Survival
Confidence Intervals
nintedanib
sorafenib
7 引文 (Scopus)

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)

Abou-Alfa, G. K., Yen, C-J., Hsu, C. H., O’Donoghue, J., Beylergil, V., Ruan, S., Pandit-Taskar, N., Gansukh, B., Lyashchenko, S. K., Ma, J., Wan, P., Shao, Y. Y., Lin, Z. Z., Frenette, C., O’Neil, B., Schwartz, L., Smith-Jones, P. M., Ohtomo, T., Tanaka, T., Morikawa, H. 及其他10, Maki, Y., Ohishi, N., Chen, Y. C., Agajanov, T., Boisserie, F., Di Laurenzio, L., Lee, R., Larson, S. M., Cheng, A. L. & Carrasquilo, J. A., 2017 二月 1, 於 : Cancer Chemotherapy and Pharmacology. 79, 2, p. 421-429 9 p.

研究成果: Article

Hepatocellular Carcinoma
Glypicans
Tumors
Hyponatremia
Antibodies, Monoclonal, Humanized
24 引文 (Scopus)

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma analysis of REACH trial results by child-pugh score

Zhu, A. X., Baron, A. D., Malfertheiner, P., Kudo, M., Kawazoe, S., Pezet, D., Weissinger, F., Brandi, G., Barone, C. A., Okusaka, T., Wada, Y., Park, J. O., Ryoo, B. Y., Cho, J. Y., Chung, H. C., Li, C. P., Yen, C-J., Lee, K. D., Chang, S. C., Yang, L. 及其他2, Abada, P. B. & Chau, I., 2017 二月 1, 於 : JAMA Oncology. 3, 2, p. 235-243 9 p.

研究成果: Article

Hepatocellular Carcinoma
Fetal Proteins
Therapeutics
Liver Neoplasms
Survival
18 引文 (Scopus)

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study

Chau, I., Peck-Radosavljevic, M., Borg, C., Malfertheiner, P., Seitz, J. F., Park, J. O., Ryoo, B. Y., Yen, C-J., Kudo, M., Poon, R., Pastorelli, D., Blanc, J. F., Chung, H. C., Baron, A. D., Okusaka, T., Bowman, L., Cui, Z. L., Girvan, A. C., Abada, P. B., Yang, L. 及其他1, Zhu, A. X., 2017 八月 1, 於 : European Journal of Cancer. 81, p. 17-25 9 p.

研究成果: Article

Hepatocellular Carcinoma
Placebos
alpha-Fetoproteins
Quality of Life
Therapeutics

Regular recreational physical activity and risk of head and neck cancer

Lin, C. L., Lee, W-T., Ou, C-Y., Hsiao, J-R., Huang, C-C., Huang, J-S., Wang, D-Y., Chen, K-C., Tsai, S-T., Fang, S-Y., Huang, T-T., Wu, J-L., Wu, Y-H., Hsueh, W-T., Yen, C-J., Lai, Y-H., Liao, H. C., Wu, S-Y., Yang, M-W., Lin, F-C. 及其他6, Chang, J-Y., Wang, Y. H., Weng, Y. L., Yang, H. C., Chen, Y. S. & Chang, J. S., 2017 四月 21, 於 : BMC cancer. 17, 1, 286.

研究成果: Article

Head and Neck Neoplasms
Tobacco Products
Vegetables
Fruit
Logistic Models
2016
6 引文 (Scopus)
betel
Tobacco
Head and Neck Neoplasms
Mastication
tobacco
4 引文 (Scopus)

Aligning to the sample-specific reference sequence to optimize the accuracy of next-generation sequencing analysis for hepatitis B virus

Liu, W. C., Lin, C. P., Cheng, C. P., Ho, C. H., Lan, K. L., Cheng, J. H., Yen, C-J., Cheng, P-N., Wu, I-C., Li, I. C., Chang, B. C. H., Tseng, V. S., Chiu, Y-C. & Chang, T-T., 2016 一月 1, 於 : Hepatology International. 10, 1, p. 147-157 11 p.

研究成果: Article

Hepatitis B virus
Nucleotides
Genotype
Clone Cells
Nucleic Acid Databases
2 引文 (Scopus)
Head and Neck Neoplasms
Immunoglobulin E
Hypersensitivity
Serum
Odds Ratio
27 引文 (Scopus)

Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma

Chen, H. A., Kuo, T. C., Tseng, C. F., Ma, J. T., Yang, S. T., Yen, C-J., Yang, C. Y., Sung, S. Y. & Su, J. L., 2016 十一月 1, 於 : Hepatology. 64, 5, p. 1637-1651 15 p.

研究成果: Article

Angiopoietins
Hepatocellular Carcinoma
Gastropoda
Neoplasms
Proteins
37 引文 (Scopus)

A randomized phase II study of FOLFOX with or without the MET inhibitor onartuzumab in advanced Adenocarcinoma of the stomach and Gastroesophageal junction

Shah, M. A., Cho, J. Y., Tan, I. B., Tebbutt, N. C., Yen, C-J., Kang, A., Shames, D. S., Bu, L. & Kang, Y. K., 2016 九月 1, 於 : Oncologist. 21, 9, p. 1085-1090 6 p.

研究成果: Article

Esophagogastric Junction
Stomach
Adenocarcinoma
Placebos
Population
15 引文 (Scopus)

HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3

Chen, J. Y., Chen, Y. J., Yen, C-J., Chen, W. S. & Huang, W. C., 2016 一月 1, 於 : Oncotarget. 7, 1, p. 473-489 17 p.

研究成果: Article

Hepatocellular Carcinoma
Cell Survival
Up-Regulation
hepatitis B virus X protein
lapatinib
37 引文 (Scopus)

Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells

Chan, T. S., Hsu, C. C., Pai, V. C., Liao, W. Y., Huang, S. S., Tan, K. T., Yen, C-J., Hsu, S. C., Chen, W. Y., Shan, Y-S., Li, C. R., Lee, M. T., Jiang, K. Y., Chu, J. M., Lien, G. S., Weaver, V. M. & Tsai, K. K., 2016 一月 1, 於 : Journal of Experimental Medicine. 213, 13, p. 2967-2988 22 p.

研究成果: Article

Neoplastic Stem Cells
Drug Therapy
Neoplasms
Therapeutics
Chemokines